Hyperfibrinolysis diagnosed by rotational thromboelastometry in a case of suspected amniotic fluid embolism

International Journal of Obstetric Anesthesia

Volumn 22, Issue 1, 2013, Pages 71-76

  Collins, N F ^a   Bloor, M ^a   McDonnell, N J ^a  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

Amniotic fluid embolism; Antifibrinolytics; Blood; Coagulation tests; Thromboelastometry; Tranexamic acid

Indexed keywords

TRANEXAMIC ACID;

ADULT; AMNION FLUID EMBOLISM; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CESAREAN SECTION; CRYOPRECIPITATE; FEMALE; FIBRINOGEN DEFECT; HEMODYNAMICS; HUMAN; HYPERFIBRINOLYSIS; HYPOFIBRINOGENEMIA; MEASUREMENT; RESPIRATORY ARREST; THROMBOELASTOMETRY;

ADULT; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; CESAREAN SECTION; DIAGNOSIS, DIFFERENTIAL; EMBOLISM, AMNIOTIC FLUID; FEMALE; HUMANS; PREGNANCY; RESPIRATORY INSUFFICIENCY; THROMBELASTOGRAPHY; TRANEXAMIC ACID;

EID: 84872330111     PISSN: 0959289X     EISSN: 15323374     Source Type: Journal    
DOI: 10.1016/j.ijoa.2012.09.008     Document Type: Article

References (27)

1. M.T. Ganter, and C.K. Hofer Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices Anesth Analg 106 2008 1366 1375
2. L. Shore-Lesserson, H.E. Manspeizer, M. DePerio, S. Francis, F. Vela-Cantos, and M.A. Ergin Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery Anesth Analg 88 1999 312 319
3. M.T. Ganter, and D.R. Spahn Active, personalized, and balanced coagulation management saves lives in patients with massive bleeding Anesthesiology 113 2010 1016 1018
4. S. Armstrong, R. Fernando, K. Ashpole, R. Simons, and M. Columb Assessment of coagulation in the obstetric population using ROTEM(R) thromboelastometry Int J Obstet Anesth 20 2011 293 298
5. D.J. Tuffnell United Kingdom amniotic fluid embolism register BJOG 112 2005 1625 1629
6. S.L. Clark, G.D. Hankins, D.A. Dudley, G.A. Dildy, and T.F. Porter Amniotic fluid embolism: analysis of the national registry Am J Obstet Gynecol 172 1995 1158 1167
7. D. Tuffnell, M. Knight, and F. Plaat Amniotic fluid embolism-an update Anaesthesia 66 2011 3 6
8. T. Annecke, T. Geisenberger, R. Kurzl, R. Penning, and B. Heindl Algorithm-based coagulation management of catastrophic amniotic fluid embolism Blood Coagul Fibrinolysis 21 2010 95 100
9. M. Brenni, M. Worn, M. Bruesch, D.R. Spahn, and M.T. Ganter Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy Acta Anaesthesiol Scand 54 2010 111 117
10. M. Carey, and D.M. Cresset Hyperfibrinolysis-is it common? Measurement and treatment including the role of thromboelastography Clin Risk 15 2009 188 191
11. M. Cortet, C. Deneux-Tharaux, and C. Dupont Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial Br J Anaesth 108 2012 984 989
12. L. de Lloyd, R. Bovington, and A. Kaye Standard haemostatic tests following major obstetric haemorrhage Int J Obstet Anesth 20 2011 135 141
13. B. Charbit, L. Mandelbrot, and E. Samain The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage J Thromb Haemost 5 2007 266 273
14. C. Huissoud, N. Carrabin, and F. Audibert Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry BJOG 116 2009 1097 1102
15. Centre for Maternal and Child Enquiries (CMACE). Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG, 2011;118(Suppl 1):1-203.
16. Sullivan, EA, Hall, B, King, JF. Maternal deaths in Australia 2003-2005. AIHW National Perinatal Statistics Unit 2007; Maternal deaths series no. 3. Cat. no. PER 42. http://www.preru.unsw.edu.au/preruweb.nsf/resources/MD3/ $file/md3a.pdf [accessed September 2012].
17. M.J. Harnett, D.L. Hepner, S. Datta, and B.S. Kodali Effect of amniotic fluid on coagulation and platelet function in pregnancy: an evaluation using thromboelastography Anaesthesia 60 2005 1068 1072
18. C.J. Lockwood, R. Bach, A. Guha, X.D. Zhou, W.A. Miller, and Y. Nemerson Amniotic fluid contains tissue factor, a potent initiator of coagulation Am J Obstet Gynecol 165 1991 1335 1341
19. A. Estelles, J. Gilabert, C. Andres, F. Espana, and J. Aznar Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy J Thromb Haemost 64 1990 281 285
20. L. Stolte, H. van Kessel, J. Seelen, T. Eskes, and T. Wagatsuma Failure to produce the syndrome of amniotic fluid embolism by infusion of amniotic fluid and meconium into monkeys Am J Obstet Gynecol 98 1967 694 697
21. S.C.L. Koh, C. Anandakumar, and S. Arulkumaran Amniotic fluid plasminogen activators and inhibitors and TAT-complex levels during 2nd trimester pregnancy and labour Blood Coagul Fibrinolysis 9 1995 121 126
22. E.H. Liu, S. Shailaja, S.C. Koh, and T.L. Lee An assessment of the effects on coagulation of midtrimester and final-trimester amniotic fluid on whole blood by Thrombelastograph analysis Anesth Analg 90 2000 333 336
23. M. Hoffman Remodeling the blood coagulation cascade J Thromb Thrombolysis 16 2003 17 20
24. S.L. Carpenter, and P. Mathew Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance Haemophilia 14 2008 1250 1254
25. D. Dirkmann, K. Gorlinger, C. Gisbertz, F. Dusse, and J. Peters Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood Anesth Analg 114 2012 1182 1188
26. H. Shakur, I. Roberts, and R. Bautista Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial Lancet 376 2010 23 32
27. H. Shakur, D. Elbourne, and M. Gulmezoglu The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial Trials 11 2010 40